The <b>EGFR Inhibitor Industry</b> was worth <b>USD 28 billion</b> in 2023 and is forecasted to reach <b>USD 45 billion</b> by 2033, growing at a CAGR of <b>5.0%</b> over the period 2024-2033. This report covers various segments and analyzes the key trends and factors influencing the market significantly.
